TrialHuman reproduction (Oxford, England)2019

Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.

E A Stewart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.